D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 60 Citations 10,378 180 World Ranking 8047 National Ranking 597

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Internal medicine

Alan R. Boobis spends much of his time researching Biochemistry, Internal medicine, Endocrinology, Microsome and Carcinogen. Urine and Enzyme are among the areas of Biochemistry where Alan R. Boobis concentrates his study. His studies in Cytochrome P450 and CYP1A2 are all subfields of Internal medicine research.

His Cytochrome P450 research integrates issues from Molecular biology, Gene expression and Hepatic stellate cell. He combines subjects such as Cytochrome, Phenacetin, Methylcholanthrene and Pyrene with his study of Microsome. His work carried out in the field of Carcinogen brings together such families of science as Polycyclic Hydrocarbons, Inhalation, Inhalation exposure and Potency.

His most cited work include:

  • IPCS framework for analyzing the relevance of a cancer mode of action for humans. (421 citations)
  • Methods of in vitro toxicology. (341 citations)
  • Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. (322 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Biochemistry, Microsome, Internal medicine, Endocrinology and Carcinogen. His study in Biochemistry concentrates on Cytochrome, Cytochrome P450, Enzyme, In vitro and Metabolism. His work carried out in the field of Cytochrome P450 brings together such families of science as Molecular biology, Gene expression and Isozyme.

His Microsome research is multidisciplinary, incorporating perspectives in Human liver, Chromatography, Phenacetin and Benzopyrene. His studies deal with areas such as Methylcholanthrene and Potency as well as Internal medicine. He has included themes like Mechanism of action and Partial agonist in his Endocrinology study.

He most often published in these fields:

  • Biochemistry (29.46%)
  • Microsome (16.96%)
  • Internal medicine (15.18%)

What were the highlights of his more recent work (between 2015-2021)?

  • Risk analysis (9.82%)
  • Environmental health (8.93%)
  • Endocrine system (4.02%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Risk analysis, Environmental health, Endocrine system, Endogeny and Hormone. His Exposure assessment study in the realm of Environmental health connects with subjects such as Veterinary Drugs. His work focuses on many connections between Exposure assessment and other disciplines, such as Food processing, that overlap with his field of interest in Biotechnology.

Research on Internal medicine and Endocrinology is a part of his Endogeny study. The concepts of his Hormone study are interwoven with issues in Ingestion and Partial agonist. His biological study deals with issues like Biochemical engineering, which deal with fields such as Carcinogen and Mode of action.

Between 2015 and 2021, his most popular works were:

  • Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement (73 citations)
  • Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society (45 citations)
  • Benchmark dose (BMD) modeling: current practice, issues, and challenges (43 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Internal medicine

Alan R. Boobis mainly investigates Risk analysis, Mode of action, Carcinogen, Toxicology and Carcinogenesis. The study incorporates disciplines such as Biotechnology and Food safety in addition to Risk analysis. In his research on the topic of Mode of action, NAPQI, Metabolite, Glutathione, Drug metabolism and Acetaminophen is strongly related with Bioinformatics.

Alan R. Boobis regularly links together related areas like Genotoxicity in his Carcinogen studies. His Genotoxicity research includes elements of Epigenetics, DNA repair and Biochemical engineering. His Carcinogenesis study combines topics in areas such as Cell, Bioassay, In silico and Computational biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Methods of in vitro toxicology.

G Eisenbrand;B Pool-Zobel;V Baker;M Balls.
Food and Chemical Toxicology (2002)

558 Citations

Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells.

C. Rodríguez-Antona;M. T. Donato;A. Boobis;R. J. Edwards.
Xenobiotica (2002)

453 Citations

Managing the challenge of chemically reactive metabolites in drug development

B. Kevin Park;Alan Boobis;Stephen Clarke;Chris E P Goldring.
Nature Reviews Drug Discovery (2011)

450 Citations

IPCS framework for analyzing the relevance of a cancer mode of action for humans.

Alan R. Boobis;John E. Doe;Barbara Heinrich-Hirsch;M. E. (Bette) Meek.
Critical Reviews in Toxicology (2006)

425 Citations

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

Zoe E Barter;Martin K Bayliss;Philip H Beaune;Alan R Boobis.
Current Drug Metabolism (2007)

361 Citations

Risk assessment of combined exposure to multiple chemicals: A WHO/IPCS framework.

M E Bette Meek;Alan R Boobis;Kevin M Crofton;Gerhard Heinemeyer.
Regulatory Toxicology and Pharmacology (2011)

331 Citations

Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.

Anna Westlind-Johnsson;Sarah Malmebo;Anna Johansson;Charlotta Otter.
Drug Metabolism and Disposition (2003)

301 Citations

Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.

Christoph Sachse;Upinder Bhambra;Gillian Smith;Tracy J. Lightfoot.
British Journal of Clinical Pharmacology (2003)

245 Citations

Scientific Opinion on the public health hazards to be covered by inspection of meat (swine)

Olivier Andreoletti;Herbert Budka;Sava Buncic;John D Collins.
EFSA Journal (2011)

234 Citations

Risk characterisation of chemicals in food and diet.

A. G. Renwick;S. M. Barlow;Irva Hertz-Picciotto;A. R. Boobis.
Food and Chemical Toxicology (2003)

231 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alan R. Boobis

Olavi Pelkonen

Olavi Pelkonen

University of Oulu

Publications: 72

Donald S. Davies

Donald S. Davies

Imperial College London

Publications: 51

Amin Rostami-Hodjegan

Amin Rostami-Hodjegan

University of Manchester

Publications: 50

Robert J. Turesky

Robert J. Turesky

University of Minnesota

Publications: 49

Ivonne M.C.M. Rietjens

Ivonne M.C.M. Rietjens

Wageningen University & Research

Publications: 45

Samuel Monroe Cohen

Samuel Monroe Cohen

University of Nebraska Medical Center

Publications: 44

Daniel W. Nebert

Daniel W. Nebert

University of Cincinnati

Publications: 38

Brian G. Lake

Brian G. Lake

University of Surrey

Publications: 35

Magnus Ingelman-Sundberg

Magnus Ingelman-Sundberg

Karolinska Institute

Publications: 34

Hannu Raunio

Hannu Raunio

University of Eastern Finland

Publications: 33

F. Peter Guengerich

F. Peter Guengerich

Vanderbilt University

Publications: 32

José V. Castell

José V. Castell

University of Valencia

Publications: 28

Robert Edwards

Robert Edwards

University of California, Irvine

Publications: 28

Melvin E. Andersen

Melvin E. Andersen

Research Triangle Park Foundation

Publications: 25

B. Kevin Park

B. Kevin Park

University of Liverpool

Publications: 24

Keiji Wakabayashi

Keiji Wakabayashi

University of Shizuoka

Publications: 24

Trending Scientists

Xing Xie

Xing Xie

Microsoft Research Asia (China)

Laura J. Niedernhofer

Laura J. Niedernhofer

University of Minnesota

Stephen M. Strittmatter

Stephen M. Strittmatter

Yale University

Rolf G. Boot

Rolf G. Boot

Leiden University

Magali Cucchiarini

Magali Cucchiarini

Saarland University

Andrew W. Murray

Andrew W. Murray

Harvard University

Denis Hatzfeld

Denis Hatzfeld

Centre national de la recherche scientifique, CNRS

Akinori Saito

Akinori Saito

Kyoto University

Armin Hansel

Armin Hansel

University of Innsbruck

Jason L. Roberts

Jason L. Roberts

Australian Antarctic Division

Richard M. Vogel

Richard M. Vogel

Tufts University

Timothy M. Shank

Timothy M. Shank

Woods Hole Oceanographic Institution

Devon L. L. Polaschek

Devon L. L. Polaschek

University of Waikato

Helmut Kerl

Helmut Kerl

University of Graz

Mathias Fink

Mathias Fink

ESPCI Paris

Something went wrong. Please try again later.